/Investor DB

Cantos Ventures — 2020 Investments

3 investments dated 2020 · listed companies and verified rows first · show all

Astranisastranis.comin𝕏Series B · Feb 2020 · $40M

Astranis designs, builds, and operates small geostationary communications satellites that provide dedicated, secure network connectivity to large enterprises, sovereign governments, and the US military.

Advanced ManufacturingDeep TechHardwareSpace TechSan Francisco, US

John Gedmark(CEO)inRyan McLinko(CTO)inMike Mancini(Executive Officer)Siamak Ebadi(Lead RF Engineer)inHall Chen(RF Payload Design)inShraddha Pandya(Talent Acquisition)

Co-investorsAndreessen HorowitzBlackRockATEL VenturesBlack FlagBoxGroupCherubic Ventures+87 more

Debutdebutbiotech.cominSeed · Jan 2020

Debut applies AI and biotechnology to discover and formulate cosmetic ingredients and beauty products, decoding skin and hair at the genomic level to create novel actives.

Advanced ManufacturingAI & Machine LearningBiotechConsumerSan Diego, US

Joshua Britton(Founder)inBrady Beauchamp(Founder)Greg Weiss(Founder)

BoardCain A. McClary(Director)in

Co-investorsGS FuturesKdT VenturesMaterial ImpactBreakout VenturesSandbox IndustriesACVC Partners+12 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Clover Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.